Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections

Journal of Clinical Investigation

Volumn 97, Issue 6, 1996, Pages 1366-1372

  Netea, Mihai G ^a   Demacker, Pierre N M ^a   Kullberg, Bart Jan ^a   Boerman, Otto C ^a   Verschueren, Ineke ^a   Stalenhoef, Anton F H ^a   Van Der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

gram negative infection; interleukin 1; lipopolysaccharide; low density lipoproteins; tumor necrosis factor

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN RECEPTOR; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR; TRITIUM; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTOXEMIA; GRAM NEGATIVE INFECTION; HYPERLIPOPROTEINEMIA; IMMUNE RESPONSE; KLEBSIELLA PNEUMONIAE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0029869015     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118556     Document Type: Article

References (36)

1. Lynn, W.A., and J. Cohen. 1995. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 20.143-158.
2. Bcutlcr, B., I.W. Milsark, and A.C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (Wash DC). 229:869-871.
3. Tracey, C.J., Y. Fong, D.O. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry. and A Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond ). 330:662-664.
4. Ashkenazi, A., S.A. Marsters, D.J. Capon, S.M. Chamow, I.S. Figari, D. Pennica, D.V. Goeddel, M.A. Palladmo, and D.H. Smith. 1991. Protection against endotoxin shock by a tumor necrosis factor immunoadhesin. Proc. Natl. Acad. Sci. USA. 88:10535-10539.
5. Wakabayashi, G., J A Gelfand, J.F. Burke, R.C. Thomson, and C.A. Dinarello. 1991. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5:338-343.
6. Mathison, J., P Tobias, E Wolfson, and R. Ulevitch 1991. Regulatory mechanisms of host responsiveness to endotoxin (lipopolysacchande). Pathobiology. 59:185-188.
7. Pugin, J., C.C. Schurer-Maly, D. Leturcq, A. Moriarty, R.J. Ulevitch, and P.S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90:2744-2751.
8. Wurfel, M.M., S.N. Kunitake, H. Lichenstein, J.P. Kane, and S.D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1025-1035.
9. Wurfel, M.M., E. Heilman, and S.D. Wright 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysacchande (LPS) by LPS-binding protein and reconstituted high density lipoprotem. J. Exp. Med. 181:1743-1754.
10. Ulevitch, R J., and A.R. Johnston. 1978. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J. Clin. Invest. 62:1313-1324.
11. Van Lenten, B.J., A.M Fogelman, M.E. Haberland, and P.A. Edwards. 1986. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 83:2704-2708.
12. Harris, H.W., C. Grunfeld, K.R. Feingold, and J.H. Rapp. 1990. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86.696-702.
13. Harns, H.W., C. Grunfeld, K.R. Feingold, T.E. Read, J.P. Kane, A.L. Jones, E.B Eichbaum, G.F. Bland, and J.H. Rapp. 1993 Chilomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin. Invest. 91:1028-1034.
14. Tahri-Jouti, R.A., and R. Chabi. 1991. Binding of endotoxin to macrophages: distinct effects of serum constituents. Immunol Invest. 20:377-386.
15. Munford, R.S., J.M. Andersen, and J.M. Dietsliy. 1981. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes. J Clin. Invest. 68:1503-1513.
16. Flegel, W A., A. Wolpl, D.N. Mannel. and H. Northoff. 1989. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect. Immun 57:2237-2245
17. Warren, H S., G.R. Riveau, F.A. de Deckker, and L.A Chedid. 1988. Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor. Infect. Immun. 56:204-212.
18. Hubsch, A.P., F.S. Powell, P G. Lerch, and J.E. Doran. 1993. A reconstituted, apolipoprotein A-1 containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circulatory Shock. 40:14-23.
19. Levine, D.M., T.S. Parker, T.M. Donelly, A. Walsh, and A.L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci USA. 90:12040-12044.
20. Feingold, K.R., J L Funk, A.H. Moser, J.K Shigenaga, J H Rapp, and C. Grunfeld. 1995. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immun 63:2041-2046.
21. Read, T.E., C Grunfeld, Z.L. Kumwenda, M.C. Calhoun, J.P. Kane, K.R. Feingold, and J.H. Rapp 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182 267-272.
22. Ishibashi, S., M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotem receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 92:883-893.
23. Netea, M.G., W L. Blok, B.J. Kullberg, M. Bemelmans, M.T.E. Vogels, W.A. Buurman, and J.W.M. van der Meer. 1995. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect. Dis. 171:393-399.
24. Vogels, M.T E., E.J.B.M. Mensink, K. Ye, O.C. Boerman, C.M.M. Verschueren, C.A. Dinarello, and J.W.M. van der Meer 1994. Differential gene expression for interleukin-1 receptor antagonist, interleukin-1 (IL-1) and tumor necrosis factor (TNF) receptors and IL-1 and TNF synthesis may explain interleukin-1-induced resistance to infection J. Immunol. 153:5772-5780.
25. Watson, J., and R. Riblet. 1975. Genetic control of responses to bacterial hpopolysaccharides in mice J. Immunol. 114.1462-1468.
26. Cavaillon, J.M., C Fitting, N. Haeffner-Cavaillon, S.J. Kirsch, and H.S. Warren. 1990. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect. Immun. 58:2375-2382.
27. Peto, R., M.C. Pike, P. Armitage, N E Breslow, D.R. Cox, V. Howard, N. Mantel, K. McPherson, J. Peto, and P.G Smith. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer 35:1-39.
28. Kalbfleisch, J.D., and R.L. Prentice. 1980. The statistical analysis of failure time data. John Wiley & Sons, Inc , New York.
29. Van der Meer, J.W.M. 1988. The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection. Biotherapy. 1:19-25.
30. Van der Meer, J.W.M., M. Barza, S.M. Wolff, and C.A. Dinarello. 1988. A low dose of recombinant interleukin-1 protects granulocytopenic mice from lethal Gram-negative infection. Proc. Natl. Acad. Sci. USA. 85:620-1623.
31. Eichbaum, E.B., H.W. Harris, J.P. Kane, and J.H. Rapp. 1991. Chylomicrons can inhibit endotoxin activity in vivo. J. Surg. Res 51:413-416.
32. Basil, V . and J.L. Strominger. 1991 Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147:1567-1574.
33. Esfahani, M., R.D. Bigler, J.L. Alfieri, S. Lund-Katz, J.D. Baum, and L. Scerbo. 1993. Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes Biochim. Biophys Acta 1149:217-223.
34. Rothberg, K.G., Y.S. Ying, B.A. Kamen, and R.G.W. Anderson. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell. Biol. 111:2931-2938.
35. Leirisalo-Repo, M., M Jaattela, H. Gylling, T.A. Miettinen, and H. Repo. 1990. Phagocyte function in familial hypercholesterolemia. peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor production. Scand. J. Immunol 32:679-685.
36. Eggesbo, J.B., I. Hjermann, P.K. Lund, G.B. Joo, R. Ovstebo, and P. Kierulf. 1994. LPS-induced release of IL-1β, IL-6, IL-8, TNFα and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine. 6:521-529.